ACP-211

· ACADIA Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACP-211, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response [Phase 2]